Société
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Mablink Bioscience is a biotechnology company evolving in the immuno-oncology field. We are focused on continued advancement of next-generation Antibody-Drug-Conjugates (ADC) based on our linker technology platform.
Lyon, Auvergne-Rhône-Alpes, France
Envoyer un message
Français
Français
Mablink Bioscience is a French-based biotechnology company founded in 2018 developing 3rd generation Antibody-drug Conjugates (ADC) based on proprietary drug-linker technologies.
The founding members gather a unique continuum of skills in chemistry, pharmacology and immunology to develop a hydrophilic easy-to-implement platform for next-generation ADCs.
With our technology platform, we are democratizing the use of ADCs in the clinic to improve patient care in the...
Mablink Bioscience is a French-based biotechnology company founded in 2018 developing 3rd generation Antibody-drug Conjugates (ADC) based on proprietary drug-linker technologies.
The founding members gather a unique continuum of skills in chemistry, pharmacology and immunology to develop a hydrophilic easy-to-implement platform for next-generation ADCs.
With our technology platform, we are democratizing the use of ADCs in the clinic to improve patient care in the immuno-oncology field.
2
Followers